Role of Glucagon-Like Peptide-1 Analogue Versus Amylin as an Adjuvant Therapy in Type 1 Diabetes in a Closed Loop Setting With ePID Algorithm

Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes

International Journal of Pharmaceutical and Phytopharmacological Research ◽

10.51847/skbdqro7ng ◽

2021 ◽

Vol 11 (1) ◽

pp. 89-93

Keyword(s):

Type 1 Diabetes ◽

Glucagon Like Peptide ◽

Adjunctive Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Type 1 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.1804 ◽

2016 ◽

Vol 36 (9) ◽

pp. 1011-1020 ◽

Cited By ~ 8

Author(s):

Kira B. Harris ◽

Cassie L. Boland

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Faculty Opinions recommendation of Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8727957.11798054 ◽

2011 ◽

Author(s):

Kyong Soo Park ◽

Soo Heon Kwak

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review

Diabetes Obesity and Metabolism ◽

10.1111/dom.12911 ◽

2017 ◽

Vol 19 (7) ◽

pp. 915-925 ◽

Cited By ~ 4

Author(s):

Anders Albèr ◽

Andreas Brønden ◽

Filip K. Knop

Keyword(s):

Type 1 Diabetes ◽

Insulin Therapy ◽

Short Acting ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2018.1519547 ◽

2018 ◽

Vol 19 (15) ◽

pp. 1655-1661 ◽

Cited By ~ 1

Author(s):

Sheila A. Doggrell

Keyword(s):

Type 1 Diabetes ◽

Glucagon Like Peptide ◽

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

BMC Endocrine Disorders ◽

10.1186/1472-6823-3-3 ◽

2003 ◽

Vol 3 (1) ◽

Cited By ~ 55

Author(s):

Margaret T Behme ◽

John Dupré ◽

Thomas J McDonald

Keyword(s):

Type 1 Diabetes ◽

Glycemic Control ◽

Glucagon Like Peptide ◽

Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Diabetes Therapy ◽

10.1007/s13300-017-0282-3 ◽

2017 ◽

Vol 8 (4) ◽

pp. 727-738 ◽

Cited By ~ 13

Author(s):

Weihao Wang ◽

Hongyan Liu ◽

Shumin Xiao ◽

Shuaihui Liu ◽

Xin Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 1 Diabetes ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Role of oral cholecalciferol as adjuvant therapy in type 1 diabetes mellitus: randomised controlled trial

Endocrine Abstracts ◽

10.1530/endoabs.38.p187 ◽

2015 ◽

Author(s):

Shreya Sharma ◽

Niranjan Biswal ◽

Medha R ◽

Sadish Kumar Kamalanathan ◽

Adhisivam B

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Randomised Controlled Trial ◽

Adjuvant Therapy ◽

Controlled Trial ◽

Randomised Controlled

Vitamin C Further Improves the Protective Effect of Glucagon-Like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes

Diabetes Care ◽

10.2337/dc13-0750 ◽

2013 ◽

Vol 36 (12) ◽

pp. 4104-4108 ◽

Cited By ~ 31

Author(s):

A. Ceriello ◽

A. Novials ◽

E. Ortega ◽

S. Canivell ◽

L. La Sala ◽

...

Keyword(s):

Oxidative Stress ◽

Type 1 Diabetes ◽

Endothelial Dysfunction ◽

Vitamin C ◽

Protective Effect ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Acute Hypoglycemia

Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls

Annals of Clinical Biochemistry International Journal of Laboratory Medicine ◽

10.1177/0004563214544709 ◽

2015 ◽

Vol 52 (2) ◽

pp. 220-225 ◽

Cited By ~ 3

Author(s):

Karin Zibar ◽

Jadranka Knežević Ćuća ◽

Kristina Blaslov ◽

Tomislav Bulum ◽

Lea Smirčić-Duvnjak

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Healthy Controls ◽

C Peptide ◽

Negative Type ◽

Glucagon Like Peptide ◽